Doccla, a health tech startup with a platform that can monitor patients on hospital wards and in the home, has secured a $3.3 million seed funding round, led by Giant Ventures and Speedinvest. The company allows hospitals to predict when beds will be freed up by monitoring patients remotely via wearable medical devices, thus helping to alleviate bottlenecks in the system.
Founded by health entrepreneur Martin Ratz and tech entrepreneur Dag Larrson, Doccla says it has saved “thousands of bed days for the NHS,” achieving a 29% reduction in Emergency Admissions and a 20% reduction in A&E attendance, the company claimed.
Doccla is similar to competitors Current Health, Huma and Cadence. The latter recently raised $41 million in funding from Thrive and General Catalyst. The company offers a remote patient monitoring platform that enables clinicians to monitor patients at home and provide personalized feedback via texts and “video visits”. Doccla says it can also measure patients at home.
The cash raised will be used to invest in its technology, and integrate further with the medical wearables and journal record systems. It also plans to expand into European healthcare markets.
Once again, as we have seen with other technologies, Doccla’s development was propelled by the pandemic. It turned out that overwhelmed hospitals needed technologies like this to create “virtual wards” in order to monitor patients’ journeys both in the hospital and when they got home.
Dag Larsson, CEO and co-founder of Doccla said. “Our end-to-end virtual ward services are extremely easy for the care provider to take on and extremely hard for them to ignore. The NHS now faces a challenging winter season and we’re evolving our technology to support care providers.”
He added: “We differ a lot from the competition in that we support the entire patient journey (e.g. all last-mile activities like logistics, customer service, and even pre-configured mobile phones). This has made us punch substantially over our weight and win contracts with extremely high patient and clinician approval.”
Cameron McLain, managing partner and co-founder from Giant Ventures added: “Doccla provides a vital solution for a strained healthcare system, delivering a product that improves the patient experience and tackles cost.”
Felix Faltin, principal and Digital Health lead at Speedinvest, said “Doccla’s platform is more than a product, it’s a full-stack solution that makes care delivery more efficient for providers, cheaper for payors and safer for patients, long past COVID-19.”
Comment